Requirements for COVID-19 lockdowns and social distancing have shifted the healthcare provision and patient monitoring towards remote options. Although remote patient monitoring (RPM) existed even before the start of the pandemic, the gain of this technology usage was relatively low. Most commonly the remote patient monitoring (RPM) was earlier used to ensure better post-acute care and management of chronic conditions, such as diabetes. With the shift of pandemic, the technology now leads to a fundamental change in healthcare services delivery and clinical trials, says GlobalData – a leading data and analytics company.
‘Requirements for COVID-19 lockdowns and social distancing have shifted the healthcare provision and patient monitoring towards remote option technologies like remote patient monitoring (RPM). This would further help in the advancement of health technology thereby providing access even in rural areas and prevent the growing burden of chronic diseases.’
The company conducted a short survey among a total of 198 GlobalData Pharma clients and prospects, fielded from November 17, 2020 to December 11, 2020. Remote Patient Monitoring and Health Care Technology
It was observed that RPM is set to impact a new trend in the pharmaceutical industry in 2021, as per GlobalData's latest report, 'The State of the Biopharmaceutical Industry 2021'.
The COVID-19 outbreak has bestowed a unique opportunity for RPM to procure global acceptance and value.
Advertisement
These rising trends of RPM may drive a surge in other emerging industry trends such as patient empowerment, telemedicine, electronic health records, real-world evidence, and decentralized clinical trials.
Advertisement
Source-Medindia